Market Overview
According
to a new report by Market Research Future (MRFR), the global gallstone
market has been anticipated to expand at 7.9 % CAGR during the forecast period
(2017-2022) owing to the increase in gallbladder
diseases globally. Gallstones develop due to chemical
imbalance of bile inside the gallbladder. Stones generally formed as the
cholesterol level in bile increases and the cholesterol forms into stones. It has been predicted that in the UK, more than
one in every ten adults suffer from gallstones. Around 80 % of the people
suffering from gallstones don’t have pain as these are silent gallstones,
asserts American College of Gastroenterology.
Future Drivers and Restraints Impacting the Market
Major causes of gallstones
comprise blood sugar imbalance, estrogen dominance, food allergies and
sensitivities, chronic stress, low fiber
diet, low stomach acid production, obesity, rapid weight loss, low-fat diet, cholesterol-lowering
medications, and others. Moreover, the continuous
changing lifestyle coupled with unhealthy eating habits are also some of the
major factors propelling the market growth. With increasing demand for
treatment options, the gallstone market is likely to expand. Companies are
developing cost-effective products that
have minimum side effect. Several
companies are also adopting strategies for
acquisitions and launching new products to strive in the competitive market.
The competition amongst new market players is
also expected to upsurge the market growth.
Meanwhile, complications such as
infection, bleeding, bile leakage, bile duct injury,
deep vein thrombosis, post-cholecystectomy, and pain during the surgery
along with asymptomatic nature of
gallstones are predicted to slow down the
market growth over the assessment period.
Request For Free Sample Report: https://www.marketresearchfuture.com/sample_request/1935
Global Gallstone Market Segmentation
Globally, the gallstone market
has been segmented based on cause,
diagnosis, treatment, and region.
The market has been segmented
into bilirubin, cholesterol stones, concentrated bile, and others based on
cause. The most common type is the cholesterol gallstone which appears in yellow and is mainly composed of undissolved
cholesterols. According to World Gastroenterology Organisation, more than 85 %
gallstones are cholesterol stones in developed countries, among which around 20
million people in the US suffer from gallstones.
Different diagnostic procedures
covered in the market include abdominal CT scan, ultrasound, blood tests, gallbladder
radionuclide scan, and others. The ultrasound is the most commonly used
diagnostic procedure for gallstone diseases. With this procedure, even the
smallest gallstones can be detected.
The market has also been segmented into laparoscopic
cholecystectomy, open cholecystectomy, medications, and others based on
treatment.
North America Estimated to Hold the Largest Share
Geographically, the market for gallstones has been spanned across North America,
Europe, Asia Pacific, and the Middle East and Africa.
North
America has been estimated to hold the largest share due to the presence of huge
patient population suffering from gallbladder disease. High spending on
healthcare along with a well-developed healthcare sector has contributed to the
global market positively.
Europe
holds the second largest position owing to the increased government for
research and development. The UK, Germany, and France are the major
contributors in this region. Ultrasound studies revealed an incidence of
0.63/100 persons per year and a prevalence of 9 to 21% in the European region,
asserts World Gastroenterology Organisation.
Browse Complete Report: https://www.marketresearchfuture.com/reports/gallstone-market-1935
Moreover, Asia Pacific is anticipated to
showcase the fastest growth rate due to the presence of huge patient
population, improved healthcare infrastructure, and raising awareness
associated with gallbladder diseases. Meanwhile, the Middle East and Africa account
for the lowest market share in the gallstone market globally.
Competition Analysis
The prominent players operating the growth of
the market comprise NovaTract Surgical LLC (California), Sklar Surgical
Instruments (US), Olympus America Inc. (U.S.), Medtronic plc (Ireland),
Intuitive Surgical Inc. (California), Fortimedix Surgical, Levita Magnetics (California),
Simulab Corporation (US), and others.
No comments:
Post a Comment